OXB — Oxford BioMedica Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Oxford BioMedica, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	46.7	109	141	104	60.6
Net Total Accounts Receivable
Net Total Receivables	51.4	42.1	57.6	20.4	55
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	108	164	216	141	133
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	72.3	69.7	134	75.7	64.3
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	184	237	460	252	232
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	52.5	33.3	59.7	44.3	58.3
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	71.2	49.9	256	178	175
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	113	187	205	74	57
Total Liabilities & Shareholders' Equity	184	237	460	252	232
Total Common Shares Outstanding